-
1Q15 Reported EPS of $0.77
-
Adjusted EPS (non-GAAP) of $0.81
-
1Q15 Net sales declined approximately 1 percent to $1.53 billion
-
Net sales up approximately 3 percent on organic basis
-
Returned $66 million to shareholders via share repurchases and
dividends
-
Updated FY15 Reported EPS guidance to $2.85 to $3.05, reflecting
higher anticipated restructuring charges and 1Q outperformance vs.
Company expectations
-
Increased Adjusted EPS (non-GAAP) guidance by $0.05 to $3.25 to
$3.45
GLENDALE, Calif. -- (Business Wire)
Avery Dennison Corporation (NYSE:AVY) today announced preliminary,
unaudited results for its first quarter ended April 4, 2015. All
non-GAAP financial measures referenced in this document are reconciled
to GAAP in the attached tables. Unless otherwise indicated, the
discussion of the company’s results is focused on its continuing
operations, and comparisons are to the same period in the prior year.
“We’re off to a good start, with earnings above our expectations,” said
Dean Scarborough, Avery Dennison chairman and CEO. "Sales were up 3
percent on an organic basis, reflecting another quarter of solid growth
for Pressure-sensitive Materials, and strong sequential improvement for
Retail Branding and Information Solutions. Despite the headwind from
currency translation, we delivered significant growth in adjusted
earnings, and expanded our operating margins through ongoing
productivity initiatives and improved product mix.
“We have raised our outlook for full-year adjusted earnings per share,
as we expect additional productivity improvement will offset the
incremental pressure we’ve seen from a stronger dollar,” Scarborough
added. “I am confident that the consistent execution of our strategies
for profitable growth, combined with our continued focus on productivity
and capital discipline, will enable us to meet our long-term goals."
For more details on the company’s results, see the summary table
accompanying this news release, as well as the supplemental presentation
materials, “First Quarter 2015 Financial Review and Analysis,” posted on
the company’s website at www.investors.averydennison.com,
and furnished to the SEC on Form 8-K.
First Quarter 2015 Results by Segment
All references to sales reflect comparisons on an organic basis, which
exclude the estimated impact of currency translation, product line
exits, acquisitions and divestitures, and, where applicable, the extra
week in the prior fiscal year. Adjusted operating margin refers to
income before interest expense and taxes, excluding restructuring costs
and other items, as a percentage of sales.
Pressure-sensitive Materials (PSM)
-
PSM sales increased approximately 4 percent. Within the segment, Label
and Packaging Materials increased low-single digits. Combined sales of
Graphics and Performance Tapes increased mid-single digits.
-
Operating margin improved 120 basis points to 11 percent as the
benefit of favorable product mix and higher volume, combined with
productivity, more than offset higher employee-related costs and
increased restructuring charges. Adjusted operating margin improved
160 basis points.
Retail Branding and Information Solutions (RBIS)
-
RBIS sales were up approximately 2 percent.
-
Operating margin improved 60 basis points to 4.9 percent as the
benefit of productivity initiatives and higher volume more than offset
higher employee-related costs. Adjusted operating margin also improved
60 basis points.
Other
Share Repurchases
The company repurchased 0.6 million shares in the first quarter of 2015
at an aggregate cost of $34 million.
Income Taxes
The first quarter effective tax rate was 28 percent. The adjusted tax
rate for the first quarter was 34 percent, consistent with the
anticipated full year tax rate in the low to mid-thirty percent range.
Cost Reduction Actions
In the first quarter, the company realized approximately $10 million in
savings from restructuring, net of transition costs, and incurred
restructuring charges of approximately $14 million, nearly all of which
represent cash costs.
Outlook
In its supplemental presentation materials, “First Quarter 2015
Financial Review and Analysis,” the company provides a list of factors
that it believes will contribute to its 2015 financial results. Based on
the factors listed and other assumptions, the company now expects 2015
earnings per share of $2.85 to $3.05. Excluding an estimated $0.40 per
share for restructuring costs and other items, the company now expects
adjusted (non-GAAP) earnings per share of $3.25 to $3.45.
Note: Throughout this release and the supplemental presentation
materials, amounts on a per share basis reflect fully diluted shares
outstanding.
About Avery Dennison
Avery Dennison (NYSE:AVY) is a global leader in labeling and packaging
materials and solutions. The company’s applications and technologies are
an integral part of products used in every major market and industry.
With operations in more than 50 countries and over 25,000 employees
worldwide, Avery Dennison serves customers with insights and innovations
that help make brands more inspiring and the world more intelligent.
Headquartered in Glendale, California, the company reported sales from
continuing operations of $6.3 billion in 2014. Learn more at www.averydennison.com.
“Safe Harbor” Statement under the Private Securities Litigation
Reform Act of 1995
Certain statements contained in this document are "forward-looking
statements" intended to qualify for the safe harbor from liability
established by the Private Securities Litigation Reform Act of 1995.
These forward-looking statements, and financial or other business
targets, are subject to certain risks and uncertainties. Actual results
and trends may differ materially from historical or anticipated results
depending on a variety of factors, including but not limited to risks
and uncertainties relating to the following: fluctuations in demand
affecting sales to customers; worldwide and local economic conditions;
fluctuations in currency exchange rates and other risks associated with
foreign operations, including in emerging markets; the financial
condition and inventory strategies of customers; changes in customer
preferences; fluctuations in cost and availability of raw materials; our
ability to generate sustained productivity improvement; our ability to
achieve and sustain targeted cost reductions; the impact of competitive
products and pricing; loss of significant contracts or customers;
collection of receivables from customers; selling prices; business mix
shift; timely development and market acceptance of new products,
including sustainable or sustainably-sourced products; investment in
development activities and new production facilities; integration of
acquisitions and completion of potential dispositions; amounts of future
dividends and share repurchases; customer and supplier concentrations;
successful implementation of new manufacturing technologies and
installation of manufacturing equipment; disruptions in information
technology systems, including cyber-attacks or other intrusions to
network security; successful installation of new or upgraded information
technology systems; data security breaches; volatility of financial
markets; impairment of capitalized assets, including goodwill and other
intangibles; credit risks; our ability to obtain adequate financing
arrangements and maintain access to capital; fluctuations in interest
and tax rates; changes in tax laws and regulations, and uncertainties
associated with interpretations of such laws and regulations; outcome of
tax audits; fluctuations in pension, insurance, and employee benefit
costs; the impact of legal and regulatory proceedings, including with
respect to environmental, health and safety; changes in governmental
laws and regulations; protection and infringement of intellectual
property; changes in political conditions; the impact of epidemiological
events on the economy and our customers and suppliers; acts of war,
terrorism, and natural disasters; and other factors.
We believe that the most significant risk factors that could affect our
financial performance in the near-term include: (1) the impacts of
economic conditions on underlying demand for our products and foreign
currency fluctuations; (2) competitors' actions, including pricing,
expansion in key markets, and product offerings; and (3) the degree to
which higher costs can be offset with productivity measures and/or
passed on to customers through selling price increases, without a
significant loss of volume.
For a more detailed discussion of these and other factors, see “Risk
Factors” and “Management’s Discussion and Analysis of Results of
Operations and Financial Condition” in our 2014 Form 10-K, filed on
February 25, 2015 with the Securities and Exchange Commission. The
forward-looking statements included in this document are made only as of
the date of this document, and we undertake no obligation to update
these statements to reflect subsequent events or circumstances, other
than as may be required by law.
For more information and to listen to a live broadcast or an audio
replay of the quarterly conference call with analysts, visit the Avery
Dennison website at www.investors.averydennison.com.
|
|
First Quarter Financial Summary - Preliminary, unaudited |
(in millions, except % and per share amounts)
|
|
| |
|
| |
| |
| |
| |
| |
|
| |
| |
| |
| |
| |
| | | | | 1Q | | 1Q | | % Change vs. P/Y | | | | | | | | | | | |
| | | | | 2015 | | 2014 | | Reported | | Organic (a) | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
Net sales, by segment:
| | | | | | | | | | | | | | | | | | | | | | |
| |
Pressure-sensitive Materials
| | |
$
|
1,120.6
| | |
$
|
1,143.5
| | |
(2
|
%)
| |
4
|
%
| | | | | | | | | | | | | |
| |
Retail Branding and Information Solutions
| | | |
388.1
| | | |
387.7
| | |
0
|
%
| |
2
|
%
| | | | | | | | | | | | | |
| |
Vancive Medical Technologies
| | |
|
19.3
|
| |
|
18.9
|
| |
2
|
%
| |
11
|
%
| | | | | | | | | | | | | |
Total net sales
| | |
$
|
1,528.0
| | |
$
|
1,550.1
| | |
(1
|
%)
| |
3
|
%
| | | | | | | | | | | | | |
| | | | |
| | |
|
| | | | | As Reported (GAAP) | | | Adjusted Non-GAAP (b) |
| | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | 1Q | | 1Q | | | | % of Sales | | | 1Q | | 1Q | | | | % of Sales |
| | | | | 2015 | | 2014 | | % Change | | 2015 | | 2014 | | | 2015 | | 2014 | | % Change | | 2015 | | 2014 |
Operating income (loss) before interest and taxes, by segment:
| | | | | | | | | | | | | | | | | | | | | | |
| |
Pressure-sensitive Materials
| | |
$
|
122.9
| | |
$
|
112.0
| | | | |
11.0
|
%
| |
9.8
|
%
| | |
$
|
128.5
| | |
$
|
113.3
| | | | |
11.5
|
%
| |
9.9
|
%
|
| |
Retail Branding and Information Solutions
| | | |
19.2
| | | |
16.6
| | | | |
4.9
|
%
| |
4.3
|
%
| | | |
24.7
| | | |
22.6
| | | | |
6.4
|
%
| |
5.8
|
%
|
| |
Vancive Medical Technologies
| | | |
(2.1
|
)
| | |
(2.6
|
)
| | | |
(10.9
|
%)
| |
(13.8
|
%)
| | | |
(1.0
|
)
| | |
(2.6
|
)
| | | |
(5.2
|
%)
| |
(13.8
|
%)
|
| |
Corporate expense
| | |
|
(25.2
|
)
| |
|
(22.8
|
)
| | | | | | | | |
|
(23.1
|
)
| |
|
(22.8
|
)
| | | | | | |
Total operating income before interest and taxes / operating margin
| | |
$
|
114.8
| | |
$
|
103.2
| | |
11
|
%
| |
7.5
|
%
| |
6.7
|
%
| | |
$
|
129.1
| | |
$
|
110.5
| | |
17
|
%
| |
8.4
|
%
| |
7.1
|
%
|
| | | | | | | | | | | | | | | | | | | | | | | |
|
Interest expense
| | |
$
|
15.3
| | |
$
|
15.4
| | | | | | | | | |
$
|
15.3
| | |
$
|
15.4
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
Income from continuing operations before taxes
| | |
$
|
99.5
| | |
$
|
87.8
| | |
13
|
%
| |
6.5
|
%
| |
5.7
|
%
| | |
$
|
113.8
| | |
$
|
95.1
| | |
20
|
%
| |
7.4
|
%
| |
6.1
|
%
|
| | | | | | | | | | | | | | | | | | | | | | | |
|
Provision for income taxes
| | |
$
|
27.9
| | |
$
|
16.2
| | | | | | | | | |
$
|
38.7
| | |
$
|
31.4
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
Income from continuing operations
| | |
$
|
71.6
| | |
$
|
71.6
| | |
0
|
%
| |
4.7
|
%
| |
4.6
|
%
| | |
$
|
75.1
| | |
$
|
63.7
| | |
18
|
%
| |
4.9
|
%
| |
4.1
|
%
|
| | | | | | | | | | | | | | | | | | | | | | | |
|
Loss from discontinued operations, net of tax
| | | |
---
| | | |
($0.4
|
)
| |
n/m
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
Net income
| | |
$
|
71.6
| | |
$
|
71.2
| | |
1
|
%
| |
4.7
|
%
| |
4.6
|
%
| | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
Net income per common share, assuming dilution:
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
Continuing operations
| | |
$
|
0.77
| | |
$
|
0.73
| | |
5
|
%
| | | | | | |
$
|
0.81
| | |
$
|
0.65
| | |
25
|
%
| | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
Discontinued operations
| | | |
---
| | | |
---
| | |
n/m
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
Total Company
| | |
$
|
0.77
| | |
$
|
0.73
| | |
5
|
%
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | 2015 | | 2014 | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
1Q Free Cash Flow from Continuing Operations (c) | | | | | | | | | |
$
|
(16.0
|
)
| |
$
|
(155.4
|
)
| | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | |
|
(a)
| |
Percentage change in sales excluding the estimated impact of
currency translation, product line exits, acquisitions and
divestitures, and, where applicable, the extra week in the prior
fiscal year.
|
(b)
| |
Excludes restructuring costs and other items (see accompanying
schedules A-2 to A-4 for reconciliation to GAAP financial measures).
|
(c)
| |
Free cash flow refers to cash flow from operations, less payments
for property, plant and equipment, software and other deferred
charges, plus proceeds from sales of property, plant and
equipment, plus (minus) net proceeds from sales (purchases) of
investments. Free cash flow excludes uses of cash that do not
directly or immediately support the underlying business, such as
discretionary debt reductions, dividends, share repurchases, and
certain effects of acquisitions and divestitures (e.g., cash flow
from discontinued operations, taxes, and transaction costs).
|
| |
| | | |
|
|
| |
|
| A-1 |
AVERY DENNISON |
PRELIMINARY CONSOLIDATED STATEMENTS OF INCOME |
(In millions, except per share amounts) |
| | | | | |
|
| | | (UNAUDITED) |
| | | | | |
|
| | | Three Months Ended |
| | | | | |
|
| | | Apr. 04, 2015 | | | Mar. 29, 2014 |
|
|
|
|
|
|
|
| | | | | |
|
Net sales
| | |
$
|
1,528.0
| | |
$
|
1,550.1
| |
| | | | | |
|
Cost of products sold
| | | |
1,098.0
| | | |
1,142.9
| |
|
|
|
|
|
|
|
| | | | | |
|
Gross profit
| | | |
430.0
| | | |
407.2
| |
| | | | | |
|
Marketing, general & administrative expense
| | | |
300.9
| | | |
296.7
| |
| | | | | |
|
Interest expense
| | | |
15.3
| | | |
15.4
| |
| | | | | |
|
Other expense, net (1) | | | |
14.3
| | | |
7.3
| |
|
|
|
|
|
|
|
| | | | | |
|
Income from continuing operations before taxes
| | | |
99.5
| | | |
87.8
| |
| | | | | |
|
Provision for income taxes
| | | |
27.9
| | | |
16.2
| |
|
|
|
|
|
|
|
| | | | | |
|
Income from continuing operations
| | | |
71.6
| | | |
71.6
| |
| | | | | |
|
Loss from discontinued operations, net of tax
| | | |
---
| | | |
(0.4
|
)
|
|
|
|
|
|
|
|
| | | | | |
|
Net income | | |
$
|
71.6
| | |
$
|
71.2
| |
|
|
|
|
|
|
|
| | | | | |
|
Per share amounts: | | | | | | |
| | | | | |
|
Net income per common share, assuming dilution
| | | | | | |
| | | | | |
|
Continuing operations
| | |
$
|
0.77
| | |
$
|
0.73
| |
| | | | | |
|
Discontinued operations
| | | |
---
| | | |
---
| |
|
|
|
|
|
|
|
| | | | | |
|
Net income per common share, assuming dilution
| | |
$
|
0.77
| | |
$
|
0.73
| |
|
|
|
|
|
|
|
| | | | | |
|
Weighted-average common shares outstanding, assuming dilution
|
|
|
|
92.4
|
|
|
|
98.0
|
|
(1) |
|
"Other expense, net" for the first quarter of 2015 includes
severance and related costs of $13.5, asset impairment charges of
$.4, impairment charges on assets held for sale of $2, and
transaction costs related to a product line divestiture of $.6,
partially offset by gain on sale of asset of $1.7 and legal
settlement of $.5.
|
| |
|
| |
"Other expense, net" for the first quarter of 2014 includes
severance and related costs of $7 and asset impairment charges of
$.3.
|
| |
|
A-2 |
|
Reconciliation of Non-GAAP Financial Measures in Accordance with
SEC Regulations G and S-K |
|
We report financial results in conformity with accounting principles
generally accepted in the United States of America, or GAAP, and
also communicate with investors using certain non-GAAP financial
measures. These non-GAAP financial measures are not in accordance
with, nor are they a substitute for or superior to, the comparable
GAAP financial measures. These non-GAAP financial measures are
intended to supplement presentation of our financial results that
are prepared in accordance with GAAP. Based upon feedback from
investors and financial analysts, we believe that supplemental
non-GAAP financial measures provide information that is useful to
the assessment of our performance and operating trends, as well as
liquidity.
|
|
Our non-GAAP financial measures exclude the impact of certain
events, activities, or strategic decisions. The accounting effects
of these events, activities or decisions, which are included in the
GAAP financial measures, may make it difficult to assess our
underlying performance in a single period. By excluding the
accounting effects, both positive and negative, of certain items
(e.g., restructuring costs, asset impairments, legal settlements,
certain effects of strategic transactions and related costs, losses
from debt extinguishments, losses from curtailment and settlement of
pension obligations, gains or losses on sale of certain assets, and
other items), we believe that we are providing meaningful
supplemental information to facilitate an understanding of our core
operating results and liquidity measures. These non-GAAP financial
measures are used internally to evaluate trends in our underlying
performance, as well as to facilitate comparison to the results of
competitors for a single period. While some of the items we exclude
from GAAP financial measures recur, they tend to be disparate in
amount, frequency, or timing.
|
|
We use the following non-GAAP financial measures in the accompanying
news release and presentation:
|
|
Organic sales change refers to the increase or decrease in
sales excluding the estimated impact of currency translation,
product line exits, acquisitions and divestitures, and, where
applicable, the extra week in the prior fiscal year.
|
|
Adjusted operating margin refers to income from continuing
operations before interest expense and taxes, excluding
restructuring costs and other items, as a percentage of sales.
|
|
Adjusted tax rate refers to the anticipated full-year GAAP
tax rate adjusted for certain events.
|
|
Adjusted income from continuing operations refers to reported
income from continuing operations adjusted for tax-effected
restructuring costs and other items.
|
|
Adjusted EPS refers to reported income from continuing
operations per common share, assuming dilution, adjusted for
tax-effected restructuring costs and other items.
|
|
Free cash flow refers to cash flow from operations, less
payments for property, plant and equipment, software and other
deferred charges, plus proceeds from sales of property, plant and
equipment, plus (minus) net proceeds from sales (purchases) of
investments. Free cash flow excludes uses of cash that do not
directly or immediately support the underlying business, such as
discretionary debt reductions, dividends, share repurchases, and
certain effects of acquisitions and divestitures (e.g., cash flow
from discontinued operations, taxes, and transaction costs).
|
|
The reconciliations set forth below and in the accompanying
presentation are provided in accordance with Regulations G and S-K
and reconcile our non-GAAP financial measures with the most directly
comparable GAAP financial measures.
|
|
A-3 |
|
|
| |
|
| |
AVERY DENNISON |
PRELIMINARY RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES |
(In millions, except % and per share amounts) |
| | | | | |
|
| | | (UNAUDITED) |
| | | | | |
|
| | | Three Months Ended |
| | | | | |
|
| | | Apr. 04, 2015 | | | Mar. 29, 2014 |
|
|
|
|
|
|
|
| | | | | |
|
Reconciliation of Operating Margins: | | | | | | |
| | | | | |
|
Net sales
| | |
$
|
1,528.0
| | | |
$
|
1,550.1
| |
| | |
|
|
|
|
| | | | | |
|
Income from continuing operations before taxes
| | |
$
|
99.5
| | | |
$
|
87.8
| |
|
|
|
|
|
|
|
| | | | | |
|
Income from continuing operations before taxes as a percentage of
sales
| | | | 6.5 | % | | | | 5.7 | % |
|
|
|
|
|
|
|
| | | | | |
|
Adjustment:
| | | | | | |
Interest expense
| | |
$
|
15.3
| | | |
$
|
15.4
| |
| | |
|
|
|
|
| | | | | |
|
Operating income from continuing operations before interest expense
and taxes
| | |
$
|
114.8
| | | |
$
|
103.2
| |
|
|
|
|
|
|
|
| | | | | |
|
Operating Margins | | | | 7.5 | % | | | | 6.7 | % |
|
|
|
|
|
|
|
| | | | | |
|
Income from continuing operations before taxes
| | |
$
|
99.5
| | | |
$
|
87.8
| |
| | | | | |
|
Adjustments:
| | | | | | |
Restructuring costs:
| | | | | | |
Severance and related costs
| | | |
13.5
| | | | |
7.0
| |
Asset impairment charges
| | | |
0.4
| | | | |
0.3
| |
Other items(1) | | | |
0.4
| | | | |
---
| |
Interest expense
| | | |
15.3
| | | | |
15.4
| |
| | |
|
|
|
|
Adjusted operating income from continuing operations before interest
expense and taxes (non-GAAP)
| | |
$
|
129.1
| | | |
$
|
110.5
| |
|
|
|
|
|
|
|
| | | | | |
|
Adjusted Operating Margins (non-GAAP) | | | | 8.4 | % | | | | 7.1 | % |
|
|
|
|
|
|
|
| | | | | |
|
| | | | | |
|
Reconciliation of GAAP to Non-GAAP Income from Continuing
Operations: | | | | | | |
| | | | | |
|
As reported income from continuing operations
| | |
$
|
71.6
| | | |
$
|
71.6
| |
Non-GAAP adjustments, net of tax:
| | | | | | |
Restructuring costs and other items(2) | | | |
3.5
| | | | |
(7.9
|
)
|
|
|
|
|
|
|
|
| | | | | |
|
Adjusted Non-GAAP Income from Continuing Operations | | |
$
|
75.1
| | | |
$
|
63.7
| |
|
|
|
|
|
|
|
|
|
|
|
| | | | | | | | | |
|
A-3 |
(continued) |
|
|
| |
|
| |
AVERY DENNISON |
PRELIMINARY RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES |
(In millions, except % and per share amounts) |
| | | | | |
|
| | | (UNAUDITED) |
| | | | | |
|
| | | Three Months Ended |
| | | Apr. 04, 2015 | | | Mar. 29, 2014 |
|
|
|
|
|
|
|
| | | | | |
|
Reconciliation of GAAP to Non-GAAP Income per Common Share from
Continuing Operations: | | | |
| | | | | | | | | |
|
As reported income per common share from continuing operations,
assuming dilution
| | |
$
|
0.77
| |
| |
$
|
0.73
| |
Non-GAAP adjustments per common share, net of tax:
| | | | | |
Restructuring costs and other items(2) | | | |
0.04
| | | | |
(0.08
|
)
|
|
|
|
|
|
|
|
| | | | | |
|
Adjusted Non-GAAP Income per Common Share from Continuing
Operations, assuming dilution | | |
$
|
0.81
| |
| |
$
|
0.65
| |
|
|
|
|
|
|
|
| | | | | |
|
Weighted-average common shares outstanding, assuming dilution
| | | |
92.4
| | | | |
98.0
| |
|
|
|
|
|
|
|
| | | | | |
|
(1) Includes impairment charges on assets held for
sale, transaction costs related to a product line divestiture,
gain on sale of asset, and legal settlement.
|
| | | | | |
|
(2) Reflects restructuring costs and other items,
tax-effected at the full-year tax rate.
|
| | | | | |
|
| | | (UNAUDITED) |
| | | | | |
|
| | | Three Months Ended |
| | | Apr. 04, 2015 | | | Mar. 29, 2014 |
|
|
|
|
|
|
|
Reconciliation of GAAP to Non-GAAP Free Cash Flow: | | | | | |
| | | | | |
|
Net cash provided by (used in) operating activities
| | |
$
|
8.3
| |
| |
$
|
(108.0
|
)
|
Purchases of property, plant and equipment
| | | |
(25.3
|
)
| | | |
(38.7
|
)
|
Purchases of software and other deferred charges
| | | |
(1.4
|
)
| | | |
(8.9
|
)
|
Proceeds from sales of property, plant and equipment
| | | |
2.8
| | | | |
0.1
| |
(Purchases) sales of investments, net
| | | |
(0.4
|
)
| | | |
0.1
| |
|
|
|
|
|
|
|
| | | | | |
|
Free Cash Flow - Continuing Operations
|
|
|
$
|
(16.0
|
)
|
|
|
$
|
(155.4
|
)
|
| | | | | |
|
A-4 |
|
|
| |
| |
|
| |
| | |
| |
| |
AVERY DENNISON |
PRELIMINARY SUPPLEMENTARY INFORMATION |
(In millions, except %) |
(UNAUDITED) |
| | | | | | | | | | | | | | |
|
| | | First Quarter Ended |
| | | | | | | | | | | | | | |
|
| | |
NET SALES
| | |
OPERATING INCOME
| | |
OPERATING MARGINS
|
| | |
2015
| |
2014
| | |
2015 (1) | |
2014 (2) | | |
2015
| |
2014
|
| | | | | | | | | | | | | | |
|
Pressure-sensitive Materials
| | |
$
|
1,120.6
| |
$
|
1,143.5
| | |
$
|
122.9
| | |
$
|
112.0
| | | |
11.0
|
%
| |
9.8
|
%
|
Retail Branding and Information Solutions
| | | |
388.1
| | |
387.7
| | | |
19.2
| | | |
16.6
| | | |
4.9
|
%
| |
4.3
|
%
|
Vancive Medical Technologies
| | | |
19.3
| | |
18.9
| | | |
(2.1
|
)
| | |
(2.6
|
)
| | |
(10.9
|
%)
| |
(13.8
|
%)
|
Corporate Expense
| | |
|
N/A
| |
|
N/A
| | |
|
(25.2
|
)
| |
|
(22.8
|
)
| | |
N/A
|
| |
N/A
|
|
| | | | | | | | | | | | | | |
|
TOTAL FROM CONTINUING OPERATIONS
| | |
$
|
1,528.0
| |
$
|
1,550.1
| | |
$
|
114.8
|
| |
$
|
103.2
|
| | |
7.5
|
%
| |
6.7
|
%
|
| | | | | | | | | | | | | | |
|
(1) Operating income for the first quarter of 2015 includes
severance and related costs of $13.5, asset impairment charges of
$.4, impairment charges on assets held for sale of $2, and
transaction costs related to a product line divestiture of $.6,
partially offset by gain on sale of asset of $1.7 and legal
settlement of $.5. Of the total $14.3, the Pressure-sensitive
Materials segment recorded $5.6, the Retail Branding and Information
Solutions segment recorded $5.5, the Vancive Medical Technologies
segment recorded $1.1, and Corporate recorded $2.1.
|
| | | | | | | | | | | | | | |
|
(2) Operating income for the first quarter of 2014 includes
severance and related costs of $7 and asset impairment charges of
$.3. Of the total $7.3, the Pressure-sensitive Materials segment
recorded $1.3 and the Retail Branding and Information Solutions
segment recorded $6.
|
| | | | | | | | | | | | | | |
|
|
RECONCILIATION OF GAAP TO NON-GAAP SUPPLEMENTARY INFORMATION |
| | | | | | | | | | | | | | |
|
| | | | | | | | First Quarter Ended |
| | | | | | | |
OPERATING INCOME
| |
OPERATING MARGINS
|
| | | | | | | | | | | | | | |
|
| | | | | | | |
2015
| |
2014
| | |
2015
| |
2014
|
Pressure-sensitive Materials | | | | | | | | | | | | | | | |
Operating income and margins, as reported | | | | | | | | $ | 122.9 | | | $ | 112.0 | | | | 11.0 | % | | 9.8 | % |
Adjustments:
| | | | | | | | | | | | | | | |
Restructuring costs:
| | | | | | | | | | | | | | | |
Severance and related costs
| | | | | | | | |
6.9
| | | |
1.3
| | | |
0.6
|
%
| |
0.1
|
%
|
Asset impairment charges
| | | | | | | | |
0.4
| | | |
---
| | | |
---
| | |
---
| |
Gain on sale of asset
| | | | | | | |
|
(1.7
|
)
| |
|
---
|
| | |
(0.1
|
%)
| |
---
|
|
Adjusted operating income and margins (non-GAAP) | | | | | | | | $ | 128.5 |
| | $ | 113.3 |
| | | 11.5 | % | | 9.9 | % |
| | | | | | | | | | | | | | |
|
Retail Branding and Information Solutions | | | | | | | | | | | | | | | |
Operating income and margins, as reported | | | | | | | | $ | 19.2 | | | $ | 16.6 | | | | 4.9 | % | | 4.3 | % |
Adjustments:
| | | | | | | | | | | | | | | |
Restructuring costs:
| | | | | | | | | | | | | | | |
Severance and related costs
| | | | | | | | |
3.4
| | | |
5.7
| | | |
0.9
|
%
| |
1.5
|
%
|
Asset impairment charges
| | | | | | | | |
---
| | | |
0.3
| | | |
---
| | |
---
| |
Impairment charges on assets held for sale
| | | | | | | | |
2.0
| | | |
---
| | | |
0.5
|
%
| |
---
| |
Transaction costs related to a product line divestiture
| | | | | | | | |
0.6
| | | |
---
| | | |
0.2
|
%
| |
---
| |
Legal settlement
| | | | | | | |
|
(0.5
|
)
| |
|
---
|
| | |
(0.1
|
%)
| |
---
|
|
Adjusted operating income and margins (non-GAAP) | | | | | | | | $ | 24.7 |
| | $ | 22.6 |
| | | 6.4 | % | | 5.8 | % |
| | | | | | | | | | | | | | |
|
Vancive Medical Technologies | | | | | | | | | | | | | | | |
Operating loss and margins, as reported | | | | | | | | $ | (2.1 | ) | | $ | (2.6 | ) | | | (10.9 | %) | | (13.8 | %) |
Adjustments:
| | | | | | | | | | | | | | | |
Restructuring costs:
| | | | | | | | | | | | | | | |
Severance and related costs
| | | | | | | |
|
1.1
|
| |
|
---
|
| | |
5.7
|
%
| |
---
|
|
Adjusted operating loss and margins (non-GAAP) | | | | | | | | $ | (1.0 | ) | | $ | (2.6 | ) | | | (5.2 | %) | | (13.8 | %) |
| | | | | | | | | | | | | | |
|
A-5 |
|
|
| |
|
| |
AVERY DENNISON |
PRELIMINARY CONDENSED CONSOLIDATED BALANCE SHEETS |
(In millions) |
| | | | | |
|
| | | (UNAUDITED) |
| | | | | |
|
ASSETS | | | Apr. 04, 2015 | |
| Mar. 29, 2014 |
|
|
|
|
|
|
|
| | | | | |
|
Current assets:
| | | | | | |
Cash and cash equivalents
| | |
$
|
212.5
| | | |
$
|
205.1
| |
Trade accounts receivable, net
| | | |
988.0
| | | | |
1,086.2
| |
Inventories, net
| | | |
508.9
| | | | |
547.6
| |
Assets held for sale
| | | |
17.7
| | | | |
1.3
| |
Other current assets
| | | |
237.0
| | | | |
232.8
| |
|
|
|
|
|
|
|
| | | | | |
|
Total current assets
| | | |
1,964.1
| | | | |
2,073.0
| |
| | | | | |
|
Property, plant and equipment, net
| | | |
831.2
| | | | |
919.0
| |
Goodwill
| | | |
697.0
| | | | |
760.0
| |
Other intangibles resulting from business acquisitions, net
| | | |
60.9
| | | | |
89.7
| |
Non-current deferred income taxes
| | | |
305.8
| | | | |
261.6
| |
Other assets
| | | |
453.6
| | | | |
488.0
| |
|
|
|
|
|
|
|
| | | | | |
|
| | |
$
|
4,312.6
| | | |
$
|
4,591.3
| |
|
|
|
|
|
|
|
| | | | | |
|
LIABILITIES AND SHAREHOLDERS' EQUITY | | | | | | |
|
|
|
|
|
|
|
| | | | | |
|
Current liabilities:
| | | | | | |
Short-term borrowings and current portion of long-term debt and
capital leases
| | |
$
|
265.7
| | | |
$
|
167.9
| |
Accounts payable
| | | |
825.1
| | | | |
887.3
| |
Liabilities held for sale
| | | |
17.8
| | | | |
---
| |
Other current liabilities
| | | |
498.2
| | | | |
485.3
| |
|
|
|
|
|
|
|
| | | | | |
|
Total current liabilities
| | | |
1,606.8
| | | | |
1,540.5
| |
| | | | | |
|
Long-term debt and capital leases
| | | |
945.3
| | | | |
950.4
| |
Other long-term liabilities
| | | |
734.5
| | | | |
605.4
| |
Shareholders' equity:
| | | | | | |
Common stock
| | | |
124.1
| | | | |
124.1
| |
Capital in excess of par value
| | | |
810.4
| | | | |
803.9
| |
Retained earnings
| | | |
2,175.4
| | | | |
2,051.8
| |
Treasury stock at cost
| | | |
(1,470.2
|
)
| | | |
(1,207.0
|
)
|
Accumulated other comprehensive loss
| | | |
(613.7
|
)
| | | |
(277.8
|
)
|
|
|
|
|
|
|
|
| | | | | |
|
Total shareholders' equity
| | | |
1,026.0
| | | | |
1,495.0
| |
|
|
|
|
|
|
|
| | | | | |
|
| | |
$
|
4,312.6
| | | |
$
|
4,591.3
| |
|
|
|
|
|
|
|
| | | | | |
|
A-6 |
|
|
| |
|
| |
AVERY DENNISON |
PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
(In millions) |
| | | | | |
|
| | | (UNAUDITED) |
| | | | | |
|
| | | Three Months Ended |
| | | Apr. 04, 2015 |
| | Mar. 29, 2014 |
|
|
|
|
|
|
|
| | | | | |
|
Operating Activities: | | | | | | |
Net income
| | |
$
|
71.6
| | | |
$
|
71.2
| |
| | | | | |
|
Adjustments to reconcile net income to net cash provided by (used
in) operating activities:
| | | | | | |
Depreciation
| | | |
33.2
| | | | |
33.6
| |
Amortization
| | | |
16.1
| | | | |
16.4
| |
Provision for doubtful accounts and sales returns
| | | |
9.8
| | | | |
7.3
| |
Net losses from asset impairments and sales/disposals of assets
| | | |
1.1
| | | | |
0.8
| |
Stock-based compensation
| | | |
7.4
| | | | |
6.0
| |
Other non-cash expense and loss
| | | |
13.6
| | | | |
11.8
| |
Changes in assets and liabilities and other adjustments
| | | |
(144.5
|
)
| | | |
(255.1
|
)
|
|
|
|
|
|
|
|
| | | | | |
|
Net cash provided by (used in) operating activities
| | | |
8.3
| | | | |
(108.0
|
)
|
|
|
|
|
|
|
|
| | | | | |
|
Investing Activities: | | | | | | |
Purchases of property, plant and equipment
| | | |
(25.3
|
)
| | | |
(38.7
|
)
|
Purchases of software and other deferred charges
| | | |
(1.4
|
)
| | | |
(8.9
|
)
|
Proceeds from sales of property, plant and equipment
| | | |
2.8
| | | | |
0.1
| |
(Purchases) sales of investments, net
| | | |
(0.4
|
)
| | | |
0.1
| |
|
|
|
|
|
|
|
| | | | | |
|
Net cash used in investing activities
| | | |
(24.3
|
)
| | | |
(47.4
|
)
|
|
|
|
|
|
|
|
| | | | | |
|
Financing Activities: | | | | | | |
Net increase in borrowings (maturities of 90 days or less)
| | | |
64.2
| | | | |
90.4
| |
Payments of debt (maturities longer than 90 days)
| | | |
(0.2
|
)
| | | |
(0.4
|
)
|
Dividends paid
| | | |
(31.8
|
)
| | | |
(27.8
|
)
|
Shares repurchases
| | | |
(33.8
|
)
| | | |
(59.2
|
)
|
Proceeds from exercises of stock options, net
| | | |
16.0
| | | | |
12.5
| |
Other
| | | |
(8.4
|
)
| | | |
(3.2
|
)
|
|
|
|
|
|
|
|
| | | | | |
|
Net cash provided by financing activities
| | | |
6.0
| | | | |
12.3
| |
|
|
|
|
|
|
|
| | | | | |
|
Effect of foreign currency translation on cash balances
| | | |
(4.5
|
)
| | | |
(3.4
|
)
|
|
|
|
|
|
|
|
| | | | | |
|
Decrease in cash and cash equivalents
| | | |
(14.5
|
)
| | | |
(146.5
|
)
|
Cash and cash equivalents, beginning of year
| | | |
227.0
| | | | |
351.6
| |
|
|
|
|
|
|
|
| | | | | |
|
Cash and cash equivalents, end of period
| | |
$
|
212.5
| | | |
$
|
205.1
| |
|
|
|
|
|
|
|
| | | | | |
|
Contacts:
Avery Dennison Corporation
Media Relations:
Heather
Rim, 626-304-2067
heather.rim@averydennison.com
or
Investor
Relations:
Cynthia S. Guenther, 626-304-2204
investorcom@averydennison.com
Source: Avery Dennison Corporation
© 2024 Canjex Publishing Ltd. All rights reserved.